FDA Approves the First Test to Identify Risk of Opioid Addiction

The AvertD test uses a cheek swab to identify markers of potential opioid addiction.
FDA Approves the First Test to Identify Risk of Opioid Addiction
AP Photo/Toby Talbot
|Updated:
0:00

Can a test determine if you’re at risk for opioid addiction? The U.S. Food and Drug Administration (FDA) thinks so.

That’s why the agency approved the use of the AvertD test on Tuesday, a first-of-its-kind test that assesses the risk someone carries of developing opioid use disorder.

A.C. Dahnke
A.C. Dahnke
Author
A.C. Dahnke is a freelance writer and editor residing in California. She has covered community journalism and health care news for nearly a decade, winning a California Newspaper Publishers Award for her work.
Related Topics